These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 32938901)

  • 1. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
    Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
    Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kwok CS; Gale CP; Kinnaird T; Curzen N; Ludman P; Kontopantelis E; Wu J; Denwood T; Fazal N; Deanfield J; de Belder MA; Mamas M
    Heart; 2020 Dec; 106(23):1805-1811. PubMed ID: 32868280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
    Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
    Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019.
    Cammalleri V; Muscoli S; Benedetto D; Stifano G; Macrini M; Di Landro A; Di Luozzo M; Marchei M; Mariano EG; Cota L; Sergi D; Bezzeccheri A; Bonanni M; Baluci M; De Vico P; Romeo F
    J Am Heart Assoc; 2020 Oct; 9(19):e017126. PubMed ID: 32901560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
    Choudry FA; Hamshere SM; Rathod KS; Akhtar MM; Archbold RA; Guttmann OP; Woldman S; Jain AK; Knight CJ; Baumbach A; Mathur A; Jones DA
    J Am Coll Cardiol; 2020 Sep; 76(10):1168-1176. PubMed ID: 32679155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
    Li YH; Huang WC; Hwang JJ;
    Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Çinier G; Hayıroğlu M; Pay L; Yumurtaş A; Tezen O; Parsova KE; Tekkesin I
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):640-645. PubMed ID: 33034585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.
    Erol MK; Kayıkçıoğlu M; Kılıçkap M; Güler A; Yıldırım A; Kahraman F; Can V; Inci S; Baysal SS; Er O; Zeybey U; Kafkas Ç; Yayla Ç; Arin CB; Aktaş I; Yalçın AA; Genç Ö
    Anatol J Cardiol; 2020 Nov; 24(5):334-342. PubMed ID: 33122486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
    Kirtane AJ; Bangalore S
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
    [No Abstract]   [Full Text] [Related]  

  • 11. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.
    Huang B; Xu C; Liu H; Deng W; Yang Z; Wan J; Yan H; Cao G; Chen J; Jiang H
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):540-548. PubMed ID: 33170591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.
    Gramegna M; Baldetti L; Beneduce A; Pannone L; Falasconi G; Calvo F; Pazzanese V; Sacchi S; Pagnesi M; Moroni F; Ajello S; Melisurgo G; Agricola E; Camici PG; Scandroglio AM; Landoni G; Ciceri F; Zangrillo A; Cappelletti AM
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009413. PubMed ID: 32791953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
    Xiang D; Xiang X; Zhang W; Yi S; Zhang J; Gu X; Xu Y; Huang K; Su X; Yu B; Wang Y; Fang W; Huo Y; Ge J
    J Am Coll Cardiol; 2020 Sep; 76(11):1318-1324. PubMed ID: 32828614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York.
    Hannan EL; Wu Y; Cozzens K; Friedrich M; Tamis-Holland J; Jacobs AK; Ling FSK; King SB; Venditti FJ; Walford G; Berger PB; Kirtane AJ; Kamran M
    Am J Cardiol; 2021 Mar; 142():25-34. PubMed ID: 33301770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center.
    Abdelaziz HK; Abdelrahman A; Nabi A; Debski M; Mentias A; Choudhury T; Patel B; Saad M
    Am Heart J; 2020 Aug; 226():45-48. PubMed ID: 32497914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
    Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
    Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort.
    Kwok CS; Gale CP; Curzen N; de Belder MA; Ludman P; Lüscher TF; Kontopantelis E; Roebuck C; Denwood T; Burton T; Hains J; Deanfield JE; Mamas MA
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009654. PubMed ID: 33138626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
    Wang N; Zhang M; Su H; Huang Z; Lin Y; Zhang M
    J Int Med Res; 2020 Oct; 48(10):300060520966151. PubMed ID: 33108941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
    Lotfi AS; Capatina A; Kugelmass AD
    Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.